The Times Australia
The Times World News

.

A funding boost for NZ’s drug-buying agency Pharmac to pay for cancer drugs is welcome – but it won’t solve underlying issues

  • Written by Paula Lorgelly, Professor of Health Economics, University of Auckland, Waipapa Taumata Rau
A funding boost for NZ’s drug-buying agency Pharmac to pay for cancer drugs is welcome – but it won’t solve underlying issues

This week the coalition government made a significant investment[1] in Pharmac, increasing funding by NZ$604 million over the next four years.

In doing so, it delivered on a National Party election promise to fund 13 cancer drugs. Specifically, it will fund seven of those named during the election, while the remaining six will be replaced with “as good as or better alternatives”. In total, this will fund up to 54 new drugs, including 26 cancer drugs.

This announcement finally delivers hope[2] to many cancer patients, profits to the pharmaceutical industry[3], and a sigh of relief for MPs who had been accused of breaking an election promise[4].

It also reinforces the integrity of the Pharmac process, but it won’t change the fact that access to medicines in New Zealand lags behind other similar countries.

How does the Pharmac process work?

Pharmac[5] is an independent agency that makes decisions about whether pharmaceuticals, vaccines and medical devices deliver value to the New Zealand taxpayer. But these value decisions have to be made within the budget Pharmac is allocated each year.

Pharmac was one of the first health technology assessment agencies. It is internationally held in high regard[6] for the low prices it can negotiate, in part because it manages its own budget.

If Pharmac thinks a drug or device is cost-effective but can’t currently afford it, it puts it on an options for investment list[7]. This is essentially a waiting list that Pharmac will get to if it finds cost savings elsewhere when negotiating prices, or gets more government funding (as has just happened).

The drugs and devices on this list are ranked in order of priority using Pharmac’s factors for consideration[8]. This process is confidential to ensure Pharmac can negotiate the best prices, because if a pharmaceutical company knew it was high on the list, it wouldn’t engage as effectively in price negotiations.

Crohn's and colitis patients and supporters march on the offices of New Zealand's drug buying agency Pharmac
A bowel cancer drug on Pharmac’s waiting list since 2019 will now be funded. Lynn Grieveson/Newsroom via Getty Images[9]

Benefits beyond cancer patients

Pharmac’s waiting list is heavily criticised. Some drugs, including those it will now fund, were added many years ago.

Among these drugs, for example, Cetuximab[10] for bowel cancer was first submitted to Pharmac in May 2018 and placed on the list in December 2019. An application for Axitinib[11] for kidney cancer was received in September 2013 and ranked in March 2014, and subsequently reranked in 2019, 2021 and 2022.

National had promised to reinstate the $5 prescription charge[12] to pay for its 13 new cancer drugs (which were available in Australia in 2021 but not in New Zealand). That was estimated to bring in $280 million. So why is the government now paying $604 million?

The investment isn’t just paying for these cancer drugs. It would appear Pharmac is holding steadfast that its prioritisation of drugs delivers the most health benefit. My guess is that one of those cancer drugs the government wanted to fund sits at number 54 on the list. To fund it, the investment covers everything listed above it in the options for investment list.

It appears that while the National Party and the Cancer Control Agency Te Aho o Te Kahu said it was important to fund this cancer drug, there were other drugs considered more important and higher priority. Hence cancer patients will benefit but also people with infections, respiratory problems, osteoporosis, sexual health concerns, skin conditions, inflammatory conditions and mental health problems – an estimated 175,000 people in total.

The price of political meddling

Even more patients could benefit if the government had simply promised more money with no strings attached. During the election[13], Labour promised to increase Pharmac’s funding by $1 billion over four years. National promised an extra $724 million plus ring-fenced cancer drug funding.

Because the National Party chose to name these drugs, the suppliers will be less likely to engage in price negotiations. Providing more money without naming the drugs would have allowed for Pharmac to negotiate better, get a better price and use the latest investment to fund more than 54 drugs.

Despite this uplift in funding, drug availability in New Zealand still lags behind other similar countries. This will likely remain the case because Pharmac can only spend within its budget.

If we wanted greater access to pharmaceuticals, Pharmac would need much more money or we could change the process. Pharmac could simply make decisions and Health New Zealand Te Whatu Ora could fund it.

This is the model used by the UK’s National Health Service (NHS[14]) and National Institute for Health and Care Excellence (NICE[15]). NICE makes decisions that the NHS must fund from its health budget. Essentially, the opportunity cost[16] falls on the wider health and care system.

An alternative to more drug funding

It is possible to improve population health by addressing the social determinants of health (80% of ill health is due to socioeconomic and environmental factors) or by improving access to primary and preventive care, so patients get diagnosed earlier, which is generally cheaper.

The goverment’s decision to repeal[17] New Zealand’s smoke-free legislation and reduce funding[18] for a new, more accessible cervical screening process will cause considerable harms and costs in terms of raising demand for lung and cervical cancer treatments. It is almost as if one coalition agreement giveth and another taketh away.

The discussion of how much funding Pharmac should get and how Pharmac makes decisions (including how long it takes) will continue. An educated guess suggests this latest investment means Aotearoa New Zealand now spends 6.5% of its health budget on pharmaceuticals and less than a third[19] of this will be on oncology.

Isn’t it time to think about the 93% we spend in the rest of the health system and to make that more efficient and equitable?

References

  1. ^ significant investment (www.beehive.govt.nz)
  2. ^ hope (www.rnz.co.nz)
  3. ^ pharmaceutical industry (www.nzdoctor.co.nz)
  4. ^ breaking an election promise (newsroom.co.nz)
  5. ^ Pharmac (pharmac.govt.nz)
  6. ^ held in high regard (www.publish.csiro.au)
  7. ^ options for investment list (pharmac.govt.nz)
  8. ^ factors for consideration (pharmac.govt.nz)
  9. ^ Lynn Grieveson/Newsroom via Getty Images (www.gettyimages.com.au)
  10. ^ Cetuximab (connect.pharmac.govt.nz)
  11. ^ Axitinib (connect.pharmac.govt.nz)
  12. ^ reinstate the $5 prescription charge (www.stuff.co.nz)
  13. ^ election (theconversation.com)
  14. ^ NHS (www.nhs.uk)
  15. ^ NICE (www.nice.org.uk)
  16. ^ opportunity cost (www.valueinhealthjournal.com)
  17. ^ repeal (www.nzdoctor.co.nz)
  18. ^ reduce funding (www.rnz.co.nz)
  19. ^ less than a third (pharmac.govt.nz)

Read more https://theconversation.com/a-funding-boost-for-nzs-drug-buying-agency-pharmac-to-pay-for-cancer-drugs-is-welcome-but-it-wont-solve-underlying-issues-233205

Times Magazine

Headless CMS in Digital Twins and 3D Product Experiences

Image by freepik As the metaverse becomes more advanced and accessible, it's clear that multiple sectors will use digital twins and 3D product experiences to visualize, connect, and streamline efforts better. A digital twin is a virtual replica of ...

The Decline of Hyper-Casual: How Mid-Core Mobile Games Took Over in 2025

In recent years, the mobile gaming landscape has undergone a significant transformation, with mid-core mobile games emerging as the dominant force in app stores by 2025. This shift is underpinned by changing user habits and evolving monetization tr...

Understanding ITIL 4 and PRINCE2 Project Management Synergy

Key Highlights ITIL 4 focuses on IT service management, emphasising continual improvement and value creation through modern digital transformation approaches. PRINCE2 project management supports systematic planning and execution of projects wit...

What AI Adoption Means for the Future of Workplace Risk Management

Image by freepik As industrial operations become more complex and fast-paced, the risks faced by workers and employers alike continue to grow. Traditional safety models—reliant on manual oversight, reactive investigations, and standardised checklist...

From Beach Bops to Alpine Anthems: Your Sonos Survival Guide for a Long Weekend Escape

Alright, fellow adventurers and relaxation enthusiasts! So, you've packed your bags, charged your devices, and mentally prepared for that glorious King's Birthday long weekend. But hold on, are you really ready? Because a true long weekend warrior kn...

Effective Commercial Pest Control Solutions for a Safer Workplace

Keeping a workplace clean, safe, and free from pests is essential for maintaining productivity, protecting employee health, and upholding a company's reputation. Pests pose health risks, can cause structural damage, and can lead to serious legal an...

The Times Features

Exploring the Curriculum at a Modern Junior School in Melbourne

Key Highlights The curriculum at junior schools emphasises whole-person development, catering to children’s physical, emotional, and intellectual needs. It ensures early year...

Distressed by all the bad news? Here’s how to stay informed but still look after yourself

If you’re feeling like the news is particularly bad at the moment, you’re not alone. But many of us can’t look away – and don’t want to. Engaging with news can help us make ...

The Role of Your GP in Creating a Chronic Disease Management Plan That Works

Living with a long-term condition, whether that is diabetes, asthma, arthritis or heart disease, means making hundreds of small decisions every day. You plan your diet against m...

Troubleshooting Flickering Lights: A Comprehensive Guide for Homeowners

Image by rawpixel.com on Freepik Effectively addressing flickering lights in your home is more than just a matter of convenience; it's a pivotal aspect of both home safety and en...

My shins hurt after running. Could it be shin splints?

If you’ve started running for the first time, started again after a break, or your workout is more intense, you might have felt it. A dull, nagging ache down your shins after...

Metal Roof Replacement Cost Per Square Metre in 2025: A Comprehensive Guide for Australian Homeowners

In recent years, the trend of installing metal roofs has surged across Australia. With their reputation for being both robust and visually appealing, it's easy to understand thei...